Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1982 May;35(5):502–506. doi: 10.1136/jcp.35.5.502

Effect of total dose infusion of iron dextran on the storage iron content of the human placenta.

B B Bauminger, G Walters, J T Whicher, A B Duke
PMCID: PMC497705  PMID: 7085894

Abstract

In a series of pregnant women with iron deficiency anaemia treated by a total dose infusion of iron dextran, the non-haem iron content of the placenta at term was studied histochemically and by chemical analysis. Within a few days of the infusion the Prussian blue reaction on the placenta was very strong, but was negative by ten days after the infusion. Chemical analysis showed that both the water-insoluble fraction (haemosiderin) and the water-soluble fraction (ferritin) of the non-haem iron were increased soon after the infusion, but three weeks after the infusion they were almost the same as in untreated controls. Pinocytosis of iron dextran by the trophoblast and increased transport of transferrin-bound iron to the placenta are considered as possible causes for this large uptake of iron by the placenta.

Full text

PDF
502

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agarwal K. N., Dass A., Sharma K., Sharma K. D. Distribution of labelled iron-dextran (Fe 59 ) in pregnant and non-pregnant women. Indian J Med Res. 1971 Jul;59(7):1039–1043. [PubMed] [Google Scholar]
  2. Duke A. B., Kelleher J. Serum iron and iron binding capacity after total dose infusion of iron-dextran for iron deficiency anaemia in pregnancy. J Obstet Gynaecol Br Commonw. 1974 Nov;81(11):895–900. doi: 10.1111/j.1471-0528.1974.tb00402.x. [DOI] [PubMed] [Google Scholar]
  3. Galbraith G. M., Galbraith R. M., Faulk W. P. Immunological studies of transferrin and transferrin receptors of human placental trophoblast. Placenta. 1980 Jan-Mar;1(1):33–46. doi: 10.1016/s0143-4004(80)80014-2. [DOI] [PubMed] [Google Scholar]
  4. KALDOR I. Studies on intermediary iron metabolism. XII. Measurement of the iron derived from water soluble and water insoluble non-haem compounds (ferritin and haemosiderin iron) in liver and spleen. Aust J Exp Biol Med Sci. 1958 Apr;36(2):173–182. [PubMed] [Google Scholar]
  5. Muir A. R. On the phagocytosis of iron-dextran by the human plasmoditrophoblast. J Obstet Gynaecol Br Commonw. 1966 Dec;73(6):966–972. doi: 10.1111/j.1471-0528.1966.tb06121.x. [DOI] [PubMed] [Google Scholar]
  6. NYLANDER G. Histochemically demonstrable iron in the placental organs of the rat after intravenous administration of a high molecular ferric carbohydrate. Acta Soc Med Ups. 1954 Sep 30;59(5-6):363–371. [PubMed] [Google Scholar]
  7. Pathak U. N., Wood J. K., Sorhaindo B. A. Anemia of pregnancy treated with single intravenous dose of iron-dextran. Obstet Gynecol. 1967 Apr;29(4):500–507. [PubMed] [Google Scholar]
  8. RAMSAY W. N. The determination of iron in blood plasma or serum. Clin Chim Acta. 1957 Jun;2(3):214–220. doi: 10.1016/0009-8981(57)90105-5. [DOI] [PubMed] [Google Scholar]
  9. Wood J. K., Milner P. F., Pathak U. N. The metabolism of iron-dextran given as a total-dose infusion to iron deficient Jamaican subjects. Br J Haematol. 1968 Feb;14(2):119–129. doi: 10.1111/j.1365-2141.1968.tb01481.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES